The Clatterbridge Cancer Centre, Wirral, UK
Search for other papers by Anna Olsson-Brown in
Google Scholar
PubMed
Search for other papers by Rosemary Lord in
Google Scholar
PubMed
Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Search for other papers by Joseph Sacco in
Google Scholar
PubMed
Search for other papers by Jonathan Wagg in
Google Scholar
PubMed
Search for other papers by Mark Coles in
Google Scholar
PubMed
Search for other papers by Munir Pirmohamed in
Google Scholar
PubMed
approached to donate a blood sample in line with the Clatterbridge Biobank ethical approval. Informed consent was obtained. The presence of anti-Tg antibodies was analysed by ELISA using a human anti-thyroglobulin ELISA kit (ab178631) on serum isolated from
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Lauren Bell in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Ann Louise Hunter in
Google Scholar
PubMed
CEDM Centre of Endocrinology, Diabetes & Metabolism, Limassol, Cyprus
Search for other papers by Angelos Kyriacou in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Annice Mukherjee in
Google Scholar
PubMed
Endocrinology & Diabetes, Salford Royal NHS Foundation Trust, Salford, UK
Search for other papers by Akheel A Syed in
Google Scholar
PubMed
classification. TRAb assay The TRAb assay used in the study period was a commercial third-generation TSH receptor autoantibody enzyme linked immunosorbent assay (ELISA) kit supplied by Thermo Scientific B.R.A.H.M.S (Hennigsdorf, Germany) and
Search for other papers by Hathairat Rueangdetnarong in
Google Scholar
PubMed
Search for other papers by Rattanaporn Sekararithi in
Google Scholar
PubMed
Search for other papers by Thidarat Jaiwongkam in
Google Scholar
PubMed
Search for other papers by Sirinart Kumfu in
Google Scholar
PubMed
Search for other papers by Nipon Chattipakorn in
Google Scholar
PubMed
Search for other papers by Theera Tongsong in
Google Scholar
PubMed
Search for other papers by Phudit Jatavan in
Google Scholar
PubMed
-alpha The TNF-α ELISA (Invitrogen) is used for the quantitative determination of Hu TNF-α in human. The standard Hu TNF-α is prepared by following the protocol of ELISA kit. Determine the number of eight well strips needed for the assay. Insert these strips
Search for other papers by Rachel Forfar in
Google Scholar
PubMed
Search for other papers by Mashal Hussain in
Google Scholar
PubMed
Search for other papers by Puneet Khurana in
Google Scholar
PubMed
Search for other papers by Jennifer Cook in
Google Scholar
PubMed
Search for other papers by Steve Lewis in
Google Scholar
PubMed
Search for other papers by Dillon Popat in
Google Scholar
PubMed
Search for other papers by David Jackson in
Google Scholar
PubMed
Search for other papers by Ed McIver in
Google Scholar
PubMed
Search for other papers by Jeff Jerman in
Google Scholar
PubMed
Search for other papers by Debra Taylor in
Google Scholar
PubMed
Search for other papers by Adrian JL Clark in
Google Scholar
PubMed
Search for other papers by Li F Chan in
Google Scholar
PubMed
1-24 was purchased from Cambridge Research Biochemicals (Cleveland, UK). Homogeneous time-resolved fluorescence (HTRF) cAMP dynamic 2 assay kits were from Cisbio (Codolet, France). Progesterone ELISA kit was purchased from Cayman Chemical. GeneBLAzer
Search for other papers by Xiangyu Gao in
Google Scholar
PubMed
Search for other papers by Wanwan Sun in
Google Scholar
PubMed
Search for other papers by Yi Wang in
Google Scholar
PubMed
Search for other papers by Yawen Zhang in
Google Scholar
PubMed
Search for other papers by Rumei Li in
Google Scholar
PubMed
Search for other papers by Jinya Huang in
Google Scholar
PubMed
Search for other papers by Yehong Yang in
Google Scholar
PubMed
-linked immunesorbent assay (ELISA) in the Department of Clinical Laboratory in Huashan Hospital (Shanghai, China). All samples were measured in duplicate. GADA was detected by ELISA kit (Euroimmun AG, Lübeck, Germany) according to the instruction of the manufacturer
Search for other papers by Göran Oleröd in
Google Scholar
PubMed
Search for other papers by Lillemor Mattsson Hultén in
Google Scholar
PubMed
Search for other papers by Ola Hammarsten in
Google Scholar
PubMed
Search for other papers by Eva Klingberg in
Google Scholar
PubMed
quantification (LoQ) was 12.5 nmol/L at a CV of 8%. The free 25(OH)D concentration in serum was measured with enzyme-linked immunosorbent assay (ELISA) using a commercial kit (Future Diagnostics Solutions, Wijchen, The Netherlands), hereafter, named directly
Search for other papers by Jana Ernst in
Google Scholar
PubMed
Search for other papers by Urszula Grabiec in
Google Scholar
PubMed
Search for other papers by Kathrin Falk in
Google Scholar
PubMed
Search for other papers by Faramarz Dehghani in
Google Scholar
PubMed
Search for other papers by Kristina Schaedlich in
Google Scholar
PubMed
concentrations of leptin (high sensitive Leptin ELISA, IBL, Hamburg, Germany) and adiponectin (Quantikine® ELISA Human Total Adiponectin/Acrp30, BioVendor, Kassel, Germany) by ELISA according to manufacturer’s manual. ELISA data were normalized to the protein
Search for other papers by Giovanni Fanni in
Google Scholar
PubMed
Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed
Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed
Search for other papers by Magnus Sundbom in
Google Scholar
PubMed
Search for other papers by Susanne Hetty in
Google Scholar
PubMed
Search for other papers by Maria J Pereira in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
immediately performed, were frozen and stored at −80°C. For analyses, commercially available ELISA or multiplex kits were used: glucagon and glicentin (Mercodia, Uppsala, Sweden); total glucagon-like peptide (GLP)-1 (7-36 and 9-36) and total glucose
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Mette Bøgehave in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
OPEN, Open Patient data Explorative Network, Odense University Hospital, Region of Southern Denmark, Odense, Denmark
Search for other papers by Dorte Glintborg in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Jørgen Brodersen Gram in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Else-Marie Bladbjerg in
Google Scholar
PubMed
Department of Clinical Research, University of Southern Denmark, Odense, Denmark
Search for other papers by Marianne Skovsager Andersen in
Google Scholar
PubMed
Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Denmark
Search for other papers by Johannes Jakobsen Sidelmann in
Google Scholar
PubMed
/L × min), representing the total amount of kallikrein formed. Coagulation factors and inhibitors The plasma protein concentration of coagulation factor XII (FXII) was determined with enzyme-linked immunosorbent assay (ELISA), as described
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Kim Magaly Pabst in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Department of Nuclear Medicine, University Hospital Münster, Münster, Germany
Search for other papers by Robert Seifert in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Nader Hirmas in
Google Scholar
PubMed
Search for other papers by Martina Broecker-Preuss in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Manuel Weber in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Wolfgang Peter Fendler in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Timo Bartel in
Google Scholar
PubMed
Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany
Search for other papers by Sarah Theurer in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Ken Herrmann in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Rainer Görges in
Google Scholar
PubMed
enzyme-linked immunosorbent assay (ELISA) with an LoQ in our laboratory of 0.09 ng/mL (Medizym® Tg Rem ELISA; Medipan, Blankenfelde-Mahlow, Germany) was used. As described in the current ATA guidelines ( 1 , 8 ), a suppressed Tg <0.2 ng/mL was chosen as